EPA and DHA supplementation ( DrugBank: - )


2 diseases
IDDisease name (Link within this page)Number of trials
48Primary antiphospholipid syndrome1
49Systemic lupus erythematosus1

48. Primary antiphospholipid syndrome


Clinical trials : 5Drugs : 6 - (DrugBank : 4) / Drug target gene : 1 - Drug target pathways : 7 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

49. Systemic lupus erythematosus


Clinical trials : 993Drugs : 702 - (DrugBank : 184) / Drug target genes : 116 - Drug target pathways : 200 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries